[Retracted] Influencing Factors of Early Neurological Deterioration and Short-Term Prognosis after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke

Table 1

Univariate analysis of resulting in END of AIS patients (n,  ± s).

Influencing factors		END group (N = 71)	Non-END group (N = 141)	t/χ^2 value	value
Gender	Male	39	74	0.113	0.736
	Female	32	67
Age (years)	≥60	43	64	4.349	0.037
	<60	28	77
OTT (min)	210.45 ± 60.12	190.36 ± 70.43	2.055	0.041
NIHSS score (points)	15.48 ± 3.37	13.16 ± 2.13	2.547	0.012
Smoking	Yes	48	83	1.528	0.216
	No	23	58
Drinking	Yes	37	69	0.191	0.662
	No	34	72
Diabetes	Yes	18	19	4.623	0.032
	No	53	122
Hypertension	Yes	32	42	4.854	0.028
	No	39	99
Atrial fibrillation	Yes	21	23	5.052	0.025
	No	50	118
TOAST classification	Large atherosclerosis type	39	30	4.883	0.027
	Arteriolar occlusion type	17	83
	Psychogenic type	9	17
	Clear other etiology types	4	5
	Cryptogenic	2	6
Infarct area (cm)	Diameter ≥3	41	52	8.350	0.004
	Diameter<3	30	89
The degree of carotid stenosis	≥50%	29	37	4.697	0.030
	<50%	42	104
Infarct site	Cortex	34	83	2.301	0.129
	Subcortical	37	58
TC (mmol/L)		4.96 ± 1.24	4.57 ± 1.09	1.478	0.143
TG (mmol/L)		1.77 ± 1.89	1.91 ± 1.05	0.404	0.687
LDL-C (mmol/L)		3.15 ± 1.56	3.27 ± 1.14	0.374	0.709
HDL-C (μmol/L)		17.86 ± 5.31	17.64 ± 4.32	0.376	0.707
UA (μmol/L)		375.82 ± 154.66	363.39 ± 158.75	1.147	0.255
WBC (×109/L)		6.73 ± 1.66	6.18 ± 1.57	2.361	0.019
CRP (mg/L)		8.46 ± 2.17	6.39 ± 1.91	7.111	≤0.001
FIB (g/L)		3.22 ± 1.11	3.03 ± 0.91	1.331	0.185
D-D (mg/L)		3.32 ± 1.45	2.77 ± 1.26	2.850	0.005